University of Vermont

University Communications

Health & Medicine News

Vaccine Testing Center


UVM Clinical Trials Lead to First FDA Approved Cholera Vaccine in U.S.

Cholera outbreaks continue to plague areas like South Sudan, Eastern Uganda, and Kerala, India, but there’s hope for addressing this infectious disease: Last month, the Food and Drug Administration approved the only vaccine for use in the U.S. to protect against cholera infection. The University of Vermont’s Vaccine Testing ...

Full Story >>


Sprague Study Finds “Dense Breasts” Diagnosis Varies Widely Among Radiologists

In May, Vermont became the 28th state to adopt legislation mandating reporting of breast density information to patients. New University of Vermont (UVM) research - published July 18, 2016 in the Annals of Internal Medicine - shows that density assessment, as currently practiced, is subjective and highly variable across ...

Full Story >>

Steve Leffler, M.D.


Leffler Discusses Medical Center's Investments in Housing and Community Health

Steve Leffler, M.D., is Chief Medical Officer at the University of Vermont Medical Center. He posted the following information on the investments in housing and health the UVM Medical Center has made to the Vermont community on the UVM Medical Center HealthSource blog.

Full Story >>

Robert Gramling, M.D., D.Sc.


Gramling's JAMA Oncology Study Addresses Doctor-Patient Miscommunication

Clear communication between a doctor and patient is essential, especially when patients with advanced cancer wish to participate in decision-making about their medical treatment options, and trade-offs between quality and quantity of life emerge. A new study in JAMA Oncology finds that most of these patients report far more ...

Full Story >>


UVM Foundation Sets Multiple New Records for Fundraising at UVM

The University of Vermont Foundation set new records in its fundraising activities on behalf of the university during the fiscal year that ended June 30, 2016, surpassing historic milestones reached a year ago for both commitments and receipts from donors.

Full Story >>

Mercedes Rincon, Ph.D.


Rincon Appointed Chair of NIH Cellular and Molecular Immunology Study Section

The National Institutes of Health Center for Scientific Review has announced that internationally renowned immunobiologist Mercedes Rincon, Ph.D., University of Vermont professor of medicine, has been appointed chairperson of the Cellular and Molecular Immunology-A Study Section, Center for Scientific Review, the portal for ...

Full Story >>